Search Result "TP53 (p53)"
MDM2-p53 Antagonists Under Clinical Evaluation: A Promising Cancer Targeted Therapy for Cancer Patients Harbouring Wild-Type TP53
Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 8 Year: 2021
Author(s): Maryam Zanjirband
Determination of Both TP53 Mutation Status and the Amount of p53Protein has Limited Diagnostic Importance for Patients with OvarianCancer
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 24 Year: 2022 Page: 4293-4300
Author(s): Sebastian M. Klein,Nisar P. Malek
Role of p53 Gene in Breast Cancer: Focus on Mutation Spectrum and Therapeutic Strategies
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 30 Year: 2018 Page: 3566-3575
Author(s): Raman Preet Kaur,Kanika Vasudeva,Roshan Kumar,Anjana Munshi
p53: An Attractive Therapeutic Target for Cancer
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 2 Year: 2020 Page: 3706-3734
Author(s): Krupa R. Patel,Hitesh D. Patel
p53-Induced Apoptosis and Inhibitors of p53
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2009 Page: 2627-2640
Author(s): Surendra Kumar Nayak, Paramjit Singh Panesar, Harish Kumar
Proteomics of p53 in Diagnostics and Therapy of Acute Myeloid Leukemia
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 3 Year: 2006 Page: 199-207
Author(s): Nina Anensen, Ingvild Haaland, Clive DSantos, Werner Van Belle, Bjorn Tore Gjertsen
MicroRNA-Mutant P53 Crosstalk in Chemoresistance: A Hint to Monitor Therapy Outcome
Journal: MicroRNA
Volume: 9 Issue: 5 Year: 2020 Page: 322-335
Author(s): Andrea Speciale,Paola Monti,Gilberto Fronza,Alberto Izzotti,Paola Menichini
Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed
Journal: Current Drug Targets
Volume: 20 Issue: 11 Year: 2019 Page: 1091-1111
Author(s): Maryam Zanjirband,Soheila Rahgozar
The TP53 Gene and COVID-19 Virus: A Correlation Analysis
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 19 Issue: 1 Year: 2022 Page: 53-63
Author(s): C. Lakshmi Anand,P.K. Krishnan Namboori
FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 5 Year: 2008 Page: 342-348
Author(s): D. L. Cortinovis, F. Andriani, A. Livio, A. Fabbri, F. Perrone, B. Marcomini, S. Pilotti, L. Mariani, P. Bidoli, E. Bajetta, L. Roz, G. Sozzi